Investor Contact

Media & Investor Relations:
Troy Wichterman 
Chief Financial Officer
(425) 402 - 1400

Investor Relations

LHA Investor Relations
2121 Avenue of the Stars
Suite 2970
Los Angeles, CA 90067
Phone: 310-691-7100
Jody Cain:

Transfer Agent

Broadridge Corporate Issuer Solutions, Inc. 
P.O. Box 1342
Brentwood, New York 11717
(877) 830 - 4936

Investor Alerts

Register here to receive email notifications with updates about our press releases, stock price, SEC filings and more.

Press Releases

BioLife Solutions Announces Promotion of Caitlin Rice to Global Vice President, Customer Service

BOTHELL, Wash., May 19, 2021 /PRNewswire/ -- BioLife Solutions, Inc. (Nasdaq: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of class-defining bioproduction products and services for cell and gene therapies and the broader biopharma market, today announced the promotion of Caitlin Rice to the leadership position of Global Vice President, Customer Service, reporting to Dusty Tenney, President and Chief Operating Officer.  Rice is not related to Chief Executive Officer Michael Rice. She was previously the Senior Director, Commercial Support for the evo® cold chain management platform.

Tenney commented, "Caitlin joined SAVSU Technologies prior to SAVSU being acquired by BioLife. She quickly excelled in establishing robust customer service programs and response protocols to serve a growing base of courier partners and cell and gene therapy companies that trust the evo platform for the management and monitoring of their high value biologic shipments. In her new expanded role, we look forward to Caitlin leading and working with our global customer service organization to implement best practices across our portfolio of bioproduction tools and services."

Caitlin Rice holds a BA degree in public policy and law with honors from Trinity College and a JD degree from the University of Texas School of Law, where she was a School of Law Merit Scholar. 

About BioLife Solutions

BioLife Solutions is a leading supplier of cell and gene therapy bioproduction products and services. Our portfolio includes our proprietary CryoStor® freeze media and HypoThermosol® shipping and storage media, ThawSTAR® family of automated, water-free thawing products, evo® cold chain management system, Custom Biogenic Systems® high-capacity cryogenic freezers, Stirling Ultracold ULT freezers, and SciSafe biologic materials storage. For more information, please visit,,, and, and follow BioLife on Twitter.

Media & Investor Relations

Roderick de Greef
Chief Financial Officer
(425) 686-6002


SOURCE BioLife Solutions, Inc.